- Home
- CCM vs HBIO Comparison
CCM vs HBIO Comparison
Compare CCM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- HBIO
- Stock Information
- Founded
- CCM 1997
- HBIO 1901
- Country
- CCM China
- HBIO United States
- Employees
- CCM N/A
- HBIO N/A
- Industry
- CCM Medical/Nursing Services
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- CCM Health Care
- HBIO Industrials
- Exchange
- CCM Nasdaq
- HBIO Nasdaq
- Market Cap
- CCM 25.6M
- HBIO 24.6M
- IPO Year
- CCM 2009
- HBIO 2000
- Fundamental
- Price
- CCM $5.70
- HBIO $0.38
- Analyst Decision
- CCM
- HBIO Buy
- Analyst Count
- CCM 0
- HBIO 3
- Target Price
- CCM N/A
- HBIO $2.50
- AVG Volume (30 Days)
- CCM 26.0K
- HBIO 560.6K
- Earning Date
- CCM 09-26-2025
- HBIO 11-06-2025
- Dividend Yield
- CCM N/A
- HBIO N/A
- EPS Growth
- CCM N/A
- HBIO N/A
- EPS
- CCM N/A
- HBIO N/A
- Revenue
- CCM $51,056,841.00
- HBIO $88,750,000.00
- Revenue This Year
- CCM N/A
- HBIO N/A
- Revenue Next Year
- CCM N/A
- HBIO $7.02
- P/E Ratio
- CCM N/A
- HBIO N/A
- Revenue Growth
- CCM N/A
- HBIO N/A
- 52 Week Low
- CCM $3.80
- HBIO $0.28
- 52 Week High
- CCM $10.77
- HBIO $2.82
- Technical
- Relative Strength Index (RSI)
- CCM 47.73
- HBIO 30.04
- Support Level
- CCM $5.62
- HBIO $0.41
- Resistance Level
- CCM $6.96
- HBIO $0.44
- Average True Range (ATR)
- CCM 0.49
- HBIO 0.02
- MACD
- CCM 0.00
- HBIO -0.00
- Stochastic Oscillator
- CCM 22.25
- HBIO 1.75
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.